http://www.unboundmedicine.com/medline/ebm/research/voriconazoleUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19889902/full_citation/Antifungal_susceptibility_of_205_Candida_sp__primarily_isolated_during_invasive_candidiasis__Comparison_of_the_Vitek2_system_with_CLSI_broth_microdilution_and_Etest_methods_Bourgeois N, Dehandschoewercker L, Bertout S, et al. 
Antifungal susceptibility of 205 Candida sp. primarily isolated during invasive candidiasis. Comparison of the Vitek2 system with CLSI broth microdilution and Etest methods. [JOURNAL ARTICLE]
J Clin Microbiol 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889174/full_citation/Voriconazole_serum_concentrations_in_prophylactically_treated_acute_myelogenous_leukaemia_patients_Rüping MJ, Müller C, Vehreschild JJ, et al. 
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients. [JOURNAL ARTICLE]
Mycoses 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888810/full_citation/Infections_due_to_Phialemonium_species:_case_report_and_review_Rivero M, Hidalgo A, Alastruey-Izquierdo A, et al. 
Infections due to Phialemonium species: case report and review. [Journal Article]
Med Mycol 2009 Nov; 47(7):766-74.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887460/full_citation/Treatment_outcome_of_invasive_mould_disease_after_sequential_exposure_to_azoles_and_liposomal_amphotericin_B_Cornely OA, Maertens J, Bresnik M, et al. 
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886775/full_citation/Cerebral_phaeohyphomycosis_due_to_Rhinocladiella_mackenziei__formerly_Ramichloridium_mackenziei_:_a_taxonomic_update_and_review_of_the_literature_Taj-Aldeen SJ, Almaslamani M, Alkhal A, et al. 
Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): a taxonomic update and review of the literature. [JOURNAL ARTICLE]
Med Mycol 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886765/full_citation/Vertebral_osteomyelitis_due_to_Aspergillus_fumigatus_in_a_patient_with_chronic_granulomatous_disease_successfully_treated_with_antifungal_agents_and_interferon_gamma_Al-Tawfiq JA, Al-Abdely HM 
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. [JOURNAL ARTICLE]
Med Mycol 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19883150/full_citation/High_incidence_of_Candida_parapsilosis_candidaemia_in_non_neutropenic_critically_ill_patients:_Epidemiology_and_antifungal_susceptibility_Dizbay M, Fidan I, Kalkanci A, et al. 
High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: Epidemiology and antifungal susceptibility. [JOURNAL ARTICLE]
Scand J Infect Dis 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879507/full_citation/Aspergillus_and_the_paediatric_lung_Hatziagorou E, Walsh TJ, Tsanakas JN, et al. 
Aspergillus and the paediatric lung. [Journal Article]
Paediatr Respir Rev 2009 Dec; 10(4):178-85.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879181/full_citation/Azole_resistance_in_Aspergillus:_Proposed_nomenclature_and_breakpoints_Verweij PE, Howard SJ, Melchers WJ, et al. 
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints. [JOURNAL ARTICLE]
Drug Resist Updat 2009 Oct 28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19878457/full_citation/Continuous_infusion_of_amphotericin_B_deoxycholate:_an_innovative_low_cost_strategy_in_antifungal_treatment_Falci DR, Dos Santos RP, Wirth F, et al. 
Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment. [JOURNAL ARTICLE]
Mycoses 2009 Oct 28.
Abstract | Full Citation